Scientists in the United States have for the first time used artificial intelligence to design bacteria-infecting viruses that do not exist in nature, and then created working versions in the laboratory, a milestone that could accelerate new treatments for drug-resistant infections while sharpening long-running concerns over biosafety and biosecurity.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...
Contact us
Questions, corrections, or ideas? Send us a message here. We aim to reply by email within 24 hours.
Thank you. Your message has been sent. We aim to reply by email within 24 hours.Please enter your email address and a message.We could not send your message. Please try again in a little while.